ScreenerHero

YCBD cbdMD, Inc.

AMEX · US · Healthcare · Drug Manufacturers - Specialty & Generic · cbdmd.com
0.3948USD-3.00%Mkt Cap: 4.42M $P/E: 1.72

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oil…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.13BUSDP/E 24.9
TAK
Takeda Pharmaceutical Company Limited
$59.16BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.78BUSDP/E 65.4
GALD
Galderma Group AG
$43.33BUSDP/E 56.1
HLN
Haleon plc
$40.72BUSDP/E 18.9
SDZ
Sandoz Group AG
$34.23BUSDP/E 59.2
HLN
Haleon plc
$32.92BUSDP/E 19.1
ZTS
Zoetis Inc.
$30.20BUSDP/E 12.0
UTHR
United Therapeutics Corporation
$22.85BUSDP/E 19.1
VTRS
Viatris Inc.
$20.03BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.06BUSDP/E 110.0
NBIX
Neurocrine Biosciences, Inc.
$14.36BUSDP/E 20.7
IPN
Ipsen S.A.
$12.68BUSDP/E 22.9
ELAN
Elanco Animal Health Incorporated
$11.26BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.16BUSDP/E 27.7
KRK
Krka, d. d.
$8.71BUSDP/E 19.4
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1
HLUN-B
H. Lundbeck A/S
$6.66BUSDP/E 11.8
ALKS
Alkermes plc
$6.73BUSDP/E 105.6
HIMS
Hims & Hers Health, Inc.
$6.55BUSD

Key Statistics

Company
Market Cap4.42M USD
Enterprise Value4.66M USD
Revenue (TTM)20.93M USD
Gross Profit11.97M USD
Net Income (TTM)-2.04M USD
Revenue/Share2.15 USD
Last Price0.3948 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees42
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)1.72
P/E (Forward)-0.44
PEG—
EV/EBITDA-2.47
EV/Revenue0.22
P/S0.21
P/B0.53
EPS (TTM)0.23
EPS (Forward)-0.89
52W Range
0.38001% of range2.560
52W High2.560 USD
52W Low0.3800 USD
Profitability
Gross Margin62.37%
Oper. Margin-20.36%
EBITDA Margin-9.01%
Profit Margin-10.63%
ROE-28.24%
ROA-19.59%
Growth
Revenue Growth20.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.45M USD
CapEx (TTM)184.17K USD
FCF Margin-5.03%
FCF Yield-23.80%
Net Debt93.92K USD
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity0.11
Current Ratio2.50
Quick Ratio1.26
Book Value/Sh0.74 USD
Cash/Share0.19 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateMay 7, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.21M
Float10.91M
Insiders10.00%
Institutions8.19%
Short Interest
Short Ratio2.9d
Short % Float4.85%
Short % Out.4.56%
Shares Short511.11K
Short (prev mo.)493.25K
Technical
SMA 500.4942 (-20.1%)
SMA 2000.7432 (-46.9%)
Beta2.25
S&P 52W Chg15.84%
Avg Vol (30d)319.65K
Avg Vol (10d)76.22K
Technical Indicators
RSI (14)32.8
MACD-0.0271
MACD Signal-0.0229
MACD Hist.-0.0042
BB Upper0.5146 USD
BB Middle0.4569 USD
BB Lower0.3993 USD
BB Width25.24%
ATR (14)0.0326 USD
Vol Ratio (20d)0.17x